Ohsu Night Cancer Institute is categorized under Oncologists in Beaverton, OR and active since 2010.
Ohsu Night Cancer Institute was established in 2010, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Dianne Price, Office Manager at the company’s single location by writing to 15700 Sw Greystone Court, Beaverton, Oregon OR 97006 or by phoning (503) 203-1000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ohsu Night Cancer Institute |
| Contact Person: | Dianne Price, Office Manager |
| Address: | 15700 Sw Greystone Court, Beaverton, Oregon 97006 |
| Phone Number: | (503) 203-1000 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Ohsu Night Cancer Institute was started in 2010 to provide professional Oncologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Dianne Price, Office Manager for inquiries that concern Ohsu Night Cancer Institute by calling the company number (503) 203-1000, as your correspondence is most welcome. Additionally, the physical location of the single location of Ohsu Night Cancer Institute can be found at the coordinates 45.51366,-122.83828 as well as the street address 15700 Sw Greystone Court in Beaverton, Oregon 97006.
For its online presence, you may visit Ohsu Night Cancer Institute’s website at and engage with its social media outlets through on Twitter and on Facebook.